CRANBURY, N.J.--(BUSINESS WIRE)--Dr. Jill Biden, former second lady of the United States (2009-2017), educator and cancer advocate, will serve as the keynote speaker at CURE Media Group’s event celebrating the 2017 MPN Heroes. The MPN Heroes Recognition Program honors individuals or organizations that have made a difference in the field of rare blood cancers, known as myeloproliferative neoplasms (MPNs). The MPN Heroes Celebration Event will take place on December 8 in Atlanta, Georgia.
“We are honored to be joined by Dr. Biden whose drive and dedication to educating the community and raising awareness about cancer is exemplary. We look forward to having Dr. Biden give the keynote address at this year’s event,” said Michael J. Hennessy Jr., president of Michael J. Hennessy Associates, parent company of CURE Media Group, which is the nation’s leading digital and print media enterprise focused on patients with cancer.
To reserve a seat at the event, visit http://www.curetoday.com/events/mpn.
The MPN Heroes Recognition Program is sponsored by Incyte Corporation and CURE Media Group, publishers of CURE®magazine. Incyte partners with CURE Media Group to support the program, with CURE hosting the annual MPN Heroes Celebration Event recognizing heroes of the MPN community. Supporting the MPN community is an ongoing effort of Incyte, a global biopharmaceutical company that discovers and develops novel medicines to meet serious unmet medical needs in oncology and other diseases.
Following the death of their son, Beau Biden in 2015, Dr. Biden and former Vice President Joe Biden, helped push for a national commitment to cure cancer, which is known as the White House Cancer Moonshot. Now, they continue this through the Biden Cancer Initiative.
After four of her friends were diagnosed with breast cancer in 1993, Dr. Biden founded the Biden Breast Health Initiative in Delaware to teach young girls about the importance of early detection of breast cancer. To-date, this program has educated more than 10,000 high school girls.
About CURE®:
CURE Media Group is the leading resource for cancer updates, research and education. It combines a full suite of media products, including its industry leading website, CUREtoday.com; innovative video programs, such as CURE Connections®; a series of widely attended live events; and CURE® magazine, which reaches over 1 million readers. CURE Media Group is part of the Cranbury, New Jersey- based Michael J. Hennessy Associates, Inc., family of businesses, which includes the acclaimed OncLive® (http://www.onclive.com) platform of resources for the practicing oncologist. For more information, visit curetoday.com or mjhassoc.com.
About Incyte
Incyte Corporation is a Wilmington, Del. -based biopharmaceutical company focused on the discovery, development and commercialization of proprietary therapeutics. For additional information on Incyte, please visit the company’s website at http://www.incyte.com.
Follow @Incyte on Twitter at https://twitter.com/Incyte.
